Process for preparation of compounds of formula (I) by fermentation
By preparing vanillin and hydroxyphenyl methyl ethyl ketone through biotransformation under non-sterile conditions, the problems of complex equipment and high energy consumption in existing technologies are solved, and more economical and environmentally friendly production is achieved.
Patent Information
- Application Number
- CN202380033943.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-15
- Filing Date
- 2023-04-14
- Publication Date
- 2024-11-26
AI Technical Summary
Existing biotransformation methods for preparing vanillin and hydroxyphenyl methyl ethyl ketone require sterilization conditions, resulting in complex equipment, high energy consumption, and high costs.
A method for preparing vanillin and hydroxyphenyl methyl ethyl ketone by biotransformation in the presence of microorganisms avoids sterilization conditions and uses non-sterile equipment and simple reactors for the transformation.
It simplifies the preparation process, reduces energy consumption and costs, while maintaining yield, enabling more sustainable production.
Smart Images

Figure CN119032180A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a method for preparing a compound having formula (I), which comprises step (a), wherein a substrate is converted into a compound having formula (I) by bioconversion in the presence of a microorganism, and the method is characterized in that step (a) is carried out under non-sterile conditions, preferably under non-sterile conditions. Background Art
[0002] Vanillin can be obtained by various methods known to those skilled in the art, and notably by the following two routes:
[0003] - "Natural" routes based on biotechnological methods, especially involving the cultivation of microorganisms capable of bioconverting a fermentation substrate into vanillin. Such a process in which the fermentation substrate is ferulic acid is known in particular from patent application EP 0885968. Patent US 5017388 describes a process in which the fermentation substrate is eugenol and / or isoeugenol. These processes lead to the preparation of vanillin known as natural vanillin.
[0004] - The "synthetic" route, which involves conventional chemical reactions starting from guaiacol and not involving microorganisms. This method leads to the preparation of vanillin known as synthetic vanillin.
[0005] Finally, vanillin can also be prepared via a "bio-based" approach, where vanillin is derived from lignin. In particular, reference may be made to US2745796, DE 1132113 and the International Journal of Biology and Biotechnology by Azadbakht et al., 2004, Vol. 1, No. 4, pp. 535-537, entitled "Preparation of lignin from wood dust as vanillin source and comparison of different extraction methods", or to materials prepared from natural sources. Reference may be made in particular to WO 2019 / 020773.
[0006] Hydroxyphenylbutanone can also be obtained by various methods and in particular by bioconversion methods as described in document CN112391418.
[0007] The methods that enable the production of vanillin or hydroxyphenylbutanone, which are called "natural", are carried out in fermenters under sterile conditions. Sterilization is usually achieved by injecting steam into the apparatus used for a period of time that is usually greater than 20 min. The reagents are also usually sterilized, in particular by passing through a filter membrane. These methods are therefore cumbersome and expensive to implement and require specific equipment that can be sterilized; the energy impact of these methods is also very high.
[0008] The present invention aims to provide a process for preparing compounds of formula (I) which is easy to implement and has an improved ecological and / or energy footprint. Summary of the invention
[0009] The first subject of the present invention relates to a method for preparing a compound of formula (I), which comprises a step (a) in which a substrate is converted into a compound of formula (I) by bioconversion in the presence of a microorganism, the method being characterized in that step (a) is carried out under non-sterile conditions. DETAILED DESCRIPTION
[0010] In the context of the present invention, and unless stated otherwise, the expression "between ... and ..." includes the limit values.
[0011] In the context of the present invention, and unless otherwise indicated, growth of a microorganism refers to a process in which the microorganism multiplies. Growth results in the production of biomass.
[0012] In the context of the present invention, and unless otherwise indicated, the term "bioconversion" refers to a biotechnological process in which a microorganism converts a substrate into a bioconversion product. The microorganism may be a genetically modified wild-type strain that has been obtained by molecular biology or has been mutated, in particular by random or site-directed mutagenesis.
[0013] In the context of the present invention, and unless otherwise indicated, the term "process performed under sterile conditions" refers to a process performed under conditions that do not contain any microbes and / or microorganisms.
[0014] In the context of the present invention, and unless otherwise indicated, the term "method carried out under sterile conditions" refers to a method carried out under conditions that do not contain any microorganisms (microbe) and / or microorganisms (microorganisms), which conditions may be harmful to the microorganisms capable of converting a substrate into a compound of formula (I) for use in the context of the method of the present invention. The harmful effects on the microorganisms capable of converting a substrate into a compound of formula (I) can be measured by the degree of conversion of the substrate into a compound of formula (I).
[0015] In the context of the present invention, and unless otherwise indicated, sterility or sterilization can be obtained by any method, in particular thermal, chemical, mechanical or radiation methods, making it possible to eliminate microbes and / or microorganisms. The fluids, starting materials and / or devices used in the method according to the invention can be sterilized or sterilized. By way of example, the following methods can be mentioned in particular:
[0016] - moist heat sterilization or dry heat sterilization, performed by raising the temperature to a sufficient temperature and then maintaining this temperature for a sufficient period of time to eliminate microbes and / or microorganisms; for example, the temperature may be 121° C. and then maintained at 121° C. for a sufficient period of time to eliminate microorganisms,
[0017] - A membrane filtration or several consecutive membrane filtrations with a minimum cut-off diameter that removes any microbes and / or microorganisms.
[0018] In the context of the present invention, and unless otherwise specified, the term "reactor" refers to a container suitable for carrying out a chemical reaction. In the context of the present invention, a reactor may be used after having been made sterile or sterilized, or may be used in a non-sterile or sterilized situation.
[0019] In the context of the present invention, and unless otherwise specified, the term "fermentation" refers to any biological reaction involving microorganisms, such as bacterial growth, bioconversion, biosynthesis or biocatalysis.
[0020] In the context of the present invention, and unless otherwise indicated, the term "fermenter" refers to a reactor suitable for carrying out fermentation, such as a bioreactor. In the context of the present invention, a fermenter can be used after having been made sterile or sterilized, or used in non-sterile or sterilized conditions.
[0021] In the context of the present invention, and unless otherwise stated, compounds of formula (I) obtained by a bioconversion process may be referred to as naturally occurring compounds of formula (I).
[0022] In the context of the present invention, and unless otherwise stated, hydroxyphenylbutanone obtained by a bioconversion process may be referred to as natural hydroxyphenylbutanone.
[0023] In the context of the present invention, and unless otherwise stated, vanillin obtained by a bioconversion process may be referred to as natural vanillin.
[0024] The first aspect of the present invention relates to a method for preparing a compound of formula (I), which comprises step (a), wherein a substrate is converted into a compound of formula (I) by bioconversion in the presence of a microorganism, and the method is characterized in that step (a) is carried out under non-sterile conditions.
[0025] In the context of the present invention, compounds of formula (I) have the following formula:
[0026]
[0027] wherein n is between 0 and 5, preferably between 1 and 2,
[0028] R may be the same or different and is selected from the group consisting of OH, OR1, formyl, CO2H, an optionally substituted straight or branched alkyl chain containing 1 to 6 carbon atoms, an optionally substituted straight or branched alkenyl chain containing 1 to 6 carbon atoms.
[0029] According to a specific embodiment, R1 is selected from the group consisting of methyl, ethyl, propyl and butyl.
[0030] According to a specific embodiment, R is selected from the group consisting of formyl-CHO, OH, OMe, OEt, OPr, OBu, methyl, ethyl, -(CH2)2-C(O)-CH3, -CH=CH-C(O)-CH3, -CH=CH-CO2H, -CO2H, -CH2-OH.
[0031] According to a particular embodiment, the compound of formula (I) is selected from vanillin and hydroxyphenylbutanone.
[0032] In the context of the present invention, the microorganism may be any microorganism capable of forming a compound of formula (I) by bioconversion of an appropriate substrate. The microorganism, in particular a bacterium or fungus, may be a wild-type microorganism that has been genetically modified by molecular biology or mutated by random or site-directed mutagenesis.
[0033] Preferably, the microorganism is selected from bacteria belonging to the orders Actinomycetales, Caulobacterales or Pseudomonadales, preferably belonging to the families Streptomycetacae, Pseudonocardiaceae, Micrococcaceae, Caulobacteraceae or Pseudomonadaceae, very preferably Streptomyces setonii, Amycolatopsis sp., Streptomyces psammoticus, Amycolatopsis thermoflava, Micrococcus sp., Caulobacter segnis, Pseudomonas fluorescens. fluorescens), or a mutant thereof, even more preferably Streptomyces xitango, Amycolatopsis sp., Streptomyces sabdariffa. Preferably, the bioconversion reaction is carried out in the presence of the following available strains: strains numbered ATCC39116, DSMZ 9991, DSMZ 9992, CCTCC 2015329, CCTCC 2011265, IMI 390106 or Zyl 926 or a mutant thereof, preferably strains numbered ATCC39116, DSMZ 9991, DSMZ 9992, CCTCC 2015329, IMI 390106 or Zyl 926 or a mutant thereof and very preferably strains numbered ATCC39116, DSMZ 9991, DSMZ 9992, CCTCC2015329, IMI 390106 or Zyl 926. According to another embodiment, the microorganism may be selected from genetically modified microorganisms belonging to the following families: Saccharomyces cerevisiae, Schizosaccharomyces pombe, Escherichia coli, Corynebacterium glutamicum.
[0034] The microorganism used in the context of the present invention may also be a strain as described in WO 2014 / 102368, WO 2016 / 001203 or EP 2721148.
[0035] According to another embodiment, the microorganism is selected from fungi belonging to the following genera: Aspergillus, Pycnoporus, Penicillium, preferably belonging to the following families: Aspergillusluchuensis, Aspergillus niger, Pycnoporus cinnabarinus, Penicillium camamberti.
[0036] In the context of the present invention, a substrate can be converted into a compound of formula (I) by biotransformation.
[0037] In the context of the present invention, the substrate can be converted into hydroxyphenylbutanone by biotransformation. The substrate is typically selected from the group consisting of p-coumaric acid and p-hydroxybenzylideneacetone.
[0038] In the context of the present invention, the substrate can be converted into vanillin by bioconversion. The substrate is generally selected from the group consisting of glucose, ferulic acid, eugenol, isoeugenol, coumaric acid, caffeic acid, L-tyrosine, vanillic acid and 4-vinylguaiacol, preferably selected from glucose, ferulic acid and eugenol.
[0039] In the context of the present invention, step (a) of the method is carried out under non-sterile, preferably non-sterile conditions. In the context of the present invention, the expression "step (a) is carried out under non-sterile, preferably non-sterile conditions" means that the reactor or fermentor in which step (a) is carried out, and optionally the various feed pipes or outlet pipes of the reactor or fermentor are not sterile, preferably not sterilized, before they are used in step (a). In the context of the present invention, the expression "step (a) is carried out under non-sterile, preferably non-sterile conditions" means that the fermentation substrate and / or solvent used in step (a) are not sterile, preferably not sterilized, before they are used in step (a). In the context of the present invention, the expression "step (a) is carried out under non-sterile, preferably non-sterile conditions" means that the conversion of the biomass used for fermentation is not carried out aseptically, preferably not aseptically. In the context of the present invention, the expression "step (a) is carried out under non-sterile, preferably non-sterile conditions" means that the gas or gases used during step (a), in particular air or oxygen, are not sterile, preferably not sterilized, before their use in step (a).
[0040] It is particularly advantageous that the equipment, reagents and air or oxygen used during the bioconversion step (a) are not sterile, preferably not sterile, in particular because it enables the use of simpler equipment. The energy costs of the bioconversion process are also improved. In fact, not being sterile (preferably sterile) reduces steam consumption and reduces the carbon footprint of the process.
[0041] In the context of the present invention, step (a) can be performed batchwise or in fed-batch mode. According to another embodiment, step (a) can be performed continuously. Step (a) can also be performed in a cascade of fully stirred reactors connected in series.
[0042] According to a specific embodiment, the fermentation substrate is introduced into a reactor or fermenter. The biomass is then introduced into the reactor.
[0043] According to another particular embodiment, the fermentation substrate is introduced into a reactor containing the biomass.
[0044] Advantageously, the total concentration of the fermentation substrate and the total concentration of the compound of formula (I) is between 0.1 g / l and 50 g / l. According to a specific embodiment, the total concentration of the fermentation substrate and the total concentration of the compound of formula (I) is between 0.1 g / l and 25 g / l, preferably between 0.2 g / l and 20 g / l. According to another specific embodiment, the total concentration of the fermentation substrate and the total concentration of the compound of formula (I) is between 10 g / l and 50 g / l, preferably between 12 g / l and 40 g / l, very preferably between 15 g / l and 35 g / l.
[0045] The pH is controlled during step (a) and is between 7 and 9. The pH may optionally be adjusted by adding a base or an acid.
[0046] Step (a) is generally carried out at a temperature between 25°C and 50°C, preferably between 28°C and 45°C. Step (a) is generally carried out under stirring. Step (a) is generally carried out under air or oxygen. In the context of the present invention, the pO2 during step (a) is controlled and optionally adjusted. A person skilled in the art will be able to adjust the pO2 during step (a) to meet the needs of the microorganism capable of converting the substrate into a compound of formula (I), preferably into vanillin or hydroxyphenylbutanone, very preferably into vanillin, for use in the context of the present invention. For example, the pO2 may be between 1% and 99%, preferably 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%. The pO2 corresponds to the dissolved oxygen concentration in the bioconversion medium relative to the dissolved oxygen concentration in the absence of biomass at saturation. The pO2 can be measured in particular with a Hamilton Oxyferm FDA VP 225 O2 sensor.
[0047] Advantageously, the process of the invention is not only more sustainable due to its reduced energy consumption, but also makes it possible to obtain yields of the compound of formula (I) at least equivalent to those obtained by processes requiring aseptic or sterilization.
[0048] Typically, the bioconversion step (a) is preceded by a step (a0) during which the microorganisms are cultivated to obtain a sufficient amount of biomass. This biomass can then be used in the bioconversion process according to the invention.
[0049] The cultivation of bacteria is usually carried out in an aqueous medium in the presence of a nutrient element. Usually, the medium comprises a carbon source, an organic or inorganic nitrogen source, an inorganic salt and a growth factor. Those skilled in the art will be able to adjust the composition of the medium to meet the needs of a microorganism that can convert a substrate into a compound with formula (I) for use in the context of the method of the present invention.
[0050] The concentration of carbon source is usually between 5 and 50 g.l -1 Between, preferably between 20 and 34 g.l -1 Nitrogen sources (such as yeast extract) and growth factors are usually present in an amount between 2 and 20 g.l -1 Between, preferably between 5 and 10 g.l -1 In addition, magnesium ions (such as magnesium sulfate) can be added at a concentration between 0.1 and 5 g.l -1 Between, preferably between 0.5 and 1 g.l -1Typically, the pH of the culture is between 3 and 9, particularly between 4 and 8, and very preferably between 6 and 8. Typically, the temperature of the culture is between 10°C and 55°C, particularly preferably in the range of 30°C to 50°C, and very preferably between 35°C and 45°C.
[0051] The incubation period generally lasts between 15 minutes and 80 hours, preferably between 1 hour and 50 hours, and very preferably between 5 hours and 40 hours. The duration of the incubation period is variable and can be adjusted according to the microorganism capable of converting the substrate into a compound of formula (I) for use in the context of the present invention. For example, the incubation period may last until the carbon source (usually glucose) is almost completely consumed, preferably to a concentration of less than or equal to 15 g.l -1 , preferably less than or equal to 5g.l -1 , very preferably less than or equal to 3 g.l -1 According to another embodiment, the cultivation period may continue until 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95% of the carbon source introduced at the beginning of step (a0) has been consumed.
[0052] Step (a0) is usually carried out in a fermenter under sterile, preferably aseptic conditions.
[0053] In the context of the present invention, step (a) may be followed by a step (b) of purifying the compound of formula (I) obtained. Typically, the purification comprises a first step in which the fermentation juice is separated from the biomass.
[0054] The purification of the compound of formula (I) obtained at the end of step (a) can be carried out in particular by liquid / liquid extraction, by distillation, by crystallization, by evaporation in a wiped film evaporator, a falling film evaporator, in a zoned evaporator and / or by stripping. Nanofiltration and ultrafiltration steps can also be carried out as part of purification step (b).
[0055] The purification of the vanillin obtained at the end of step (a) can be carried out in particular by liquid / liquid extraction, by distillation, by crystallization, by evaporation in a wiped film evaporator, a falling film evaporator, in a zoned evaporator and / or by stripping. Nanofiltration and ultrafiltration steps can also be carried out as part of purification step (b). For example, the purification process can be carried out according to the methods described in WO2013 / 087795, WO 2014 / 114590, WO 2018 / 146210, WO 2021 / 019005.
[0056] According to another embodiment, vanillin can be continuously extracted from the fermenter by a vanillin separation device. For example, the purification process can be carried out according to the method described in WO 2017 / 025339. There is no particular restriction on the choice of the vanillin separation device. Preferably, the vanillin separation device is a membrane filtration device. This type of device makes it possible to recover a retentate containing microorganisms and a filtrate without microorganisms from the fermented juice. The vanillin separation device can also selectively extract vanillin from the extracted fermented juice.
[0057] The invention also relates to a compound of formula (I), preferably vanillin or hydroxyphenylbutanone, obtainable by the process according to the invention. Finally, the invention relates to the use of a compound of formula (I), preferably vanillin or hydroxyphenylbutanone, obtainable according to the invention as a flavoring agent in human and animal food or in the pharmaceutical sector, or as a fragrance in the cosmetics industry, the perfume industry and in cleaning agents.
[0058] Examples
[0059] Example 1: Cultivation
[0060] The Streptomyces xitangii ATCC 39116 strain was cultivated under the conditions described in document WO 2017 / 025339.
[0061] Examples 2 and 3: Bioconversion method according to the present invention and comparative method
[0062] The growth medium containing biomass prepared according to Example 1 was used.
[0063] The pH of the growth medium was adjusted to 8.4 by adding 30 mol % sodium hydroxide and kept constant under stirring and aeration.
[0064] A solution containing ferulic acid, 30 mol% sodium hydroxide and water is prepared. This solution is then added to a fermenter or reactor containing biomass.
[0065] condition
[0066] Table 1
[0067]
[0068] The following biotransformation results were obtained:
[0069] Table 2
[0070]
[0071] Examples 4 and 5: Bioconversion methods according to the present invention and comparative methods
[0072] The growth medium containing biomass prepared according to Example 1 was used.
[0073] The pH of the culture medium was adjusted to 8.4 and a coumaric acid solution was introduced to obtain a final concentration between 5 and 50 g / l. The reaction medium was kept at 37°C and 170 rpm for 24 hours. After 24 hours of bioconversion, the biomass was removed by centrifugation and the supernatant was filtered off and analyzed by HPLC. 4-Hydroxybenzaldehyde was obtained in the same proportion as according to Examples 4 and 5.
[0074] condition
[0075] Table 3
[0076]
[0077]
[0078] Examples 6 and 7: Bioconversion methods according to the present invention and comparative methods
[0079] The growth medium containing biomass prepared according to Example 1 was used.
[0080] 4-Hydroxybenzylideneacetone was mixed in the culture medium obtained after the growth period as described in Example 1. The mixture was incubated at 30° C. with stirring (200 rpm) for 72 hours.
[0081] After 72 h of bioconversion, the biomass was removed by centrifugation and the supernatant was filtered off and analyzed by HPLC. Hydroxyphenylbutanone was obtained in the same ratio as according to Examples 6 and 7.
[0082] condition
[0083] Table 4
[0084]
[0085] Therefore, the process according to the invention makes it possible to obtain results at least as good as the process according to Comparative Example 2 with regard to the vanillin concentration or Comparative Examples 4 and 6 for the preparation of 4-hydroxybenzaldehyde and hydroxyphenylbutanone.
[0086] The results of Table 2 show that the process according to the invention is particularly advantageous since it makes it possible in particular to reduce the steam consumption of the process and to simplify the process by not requiring sterilization of the materials involved in the process. These results were obtained while maintaining the yield of the bioconversion step (a).
Claims
1. A method for preparing a compound having formula (I) wherein n is between 0 and 5, preferably between 1 and 2, R may be the same or different and is selected from the group consisting of OH, OR1, formyl, CO2H, an optionally substituted straight or branched alkyl chain containing 1 to 6 carbon atoms, an optionally substituted straight or branched alkenyl chain containing 1 to 6 carbon atoms, R1 is selected from the group consisting of methyl, ethyl, propyl and butyl, The method comprises step (a), wherein a substrate is converted into a compound having formula (I) by bioconversion in the presence of a microorganism, and the method is characterized in that step (a) is carried out under non-sterile conditions.
2. A process for preparing a compound of formula (I), wherein step (a) is carried out under non-sterile conditions.
3. A process for the preparation of a compound of formula (I) as claimed in any one of claims 1 and 2, characterised in that the reactor or fermenter in which step (a) is carried out, and optionally various feed or outlet pipes of the reactor or fermenter, are not sterile, preferably are not sterilised, before they are used in step (a).
4. A process for the preparation of a compound of formula (I) as claimed in any one of claims 1 to 3, characterised in that the fermentation substrate and / or solvent used during step (a) is not sterile, preferably not sterilised, before its use in step (a).
5. The process for preparing a compound of formula (I) as claimed in any one of the preceding claims, characterized in that the transfer of the biomass for fermentation is not carried out under sterile conditions, preferably not under sterile conditions.
6. Process for the preparation of a compound of formula (I) as claimed in any one of the preceding claims, characterised in that the total concentration of the fermentation substrate and the total concentration of the compound of formula (I) is between 0.1 g / l and 50 g / l.
7. A process for the preparation of a compound of formula (I) as claimed in any one of the preceding claims, characterised in that the gas or gases used during step (a), preferably air or oxygen, are not sterile, preferably not sterilised, before their use in step (a).
8. The process for preparing a compound of formula (I) as claimed in any one of the preceding claims, characterized in that the fermentation substrate is introduced into the reactor or fermenter and then the biomass is introduced into the reactor.
9. The process for preparing a compound of formula (I) as claimed in any one of claims 1 to 7, characterized in that the fermentation substrate is introduced into the reactor containing the biomass.
10. The process for preparing a compound of formula (I) as claimed in any one of the preceding claims, further comprising a step (a0) of culturing a microorganism before step (a) so as to obtain a sufficient amount of biomass.
11. Process for the preparation of a compound of formula (I) as claimed in any one of the preceding claims, further comprising a step (b) of purifying the compound of formula (I) obtained at the end of step (a).
12. A process for the preparation of a compound of formula (I) as claimed in any one of the preceding claims, wherein the compound of formula (I) is selected from the group consisting of vanillin and hydroxyphenylbutanone.
